News

New Patient Mobility Agreement enables Childless Couple to get Treatment in both Malmø and Copenhagen

Nov 27, 2017

Both Swedish and Danish patients with certain types of involuntary infertility can now receive specialized treatment in Malmö and Copenhagen.

Region H and Region Skåne has reached an agreement regarding the Patient Mobility Agreement. The agreement enables patients from both Sweden and Denmark to receive medical treatment within a field of expertise that is not available in their home country. The Patient Mobility Agreement is built upon a previous existing agreement that was initiated and ended under ReproHigh – a project under Lund University. What differentiates the reactivated agreement compared to the previous one, is that the new agreement is part of ReproUnion, which includes more clinics than the old agreement. Read more about the agreement here (the article is in Swedish)

There has been media coverage in the following media:

 

 

 

MORE NEWS


Welcome back Mette Bach Dyremose

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in strategic communication, business development, and life sciences,...

read more

RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more